| Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ... The Lancet 396 (10249), 467-478, 2020 | 2766 | 2020 |
| Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort DT Arnold, FW Hamilton, A Milne, AJ Morley, J Viner, M Attwood, A Noel, ... Thorax 76 (4), 399-401, 2021 | 679 | 2021 |
| Guiding empirical antibiotic therapy in orthopaedics: the microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention E Moran, S Masters, AR Berendt, P McLardy-Smith, I Byren, BL Atkins Journal of Infection 55 (1), 1-7, 2007 | 318 | 2007 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 317 | 2021 |
| The diagnosis and management of prosthetic joint infections E Moran, I Byren, BL Atkins Journal of antimicrobial chemotherapy 65 (suppl_3), iii45-iii54, 2010 | 250 | 2010 |
| Oxford handbook of infectious diseases and microbiology E Torok, E Moran, F Cooke OUP Oxford, 2009 | 181 | 2009 |
| Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial GE Thwaites, M Scarborough, A Szubert, E Nsutebu, R Tilley, J Greig, ... The Lancet 391 (10121), 668-678, 2018 | 177 | 2018 |
| Increased frequencies of CD4+CD25high regulatory T cells in acute dengue infection K Lühn, CP Simmons, E Moran, NTP Dung, TNB Chau, NTH Quyen, ... The Journal of experimental medicine 204 (5), 979-985, 2007 | 165 | 2007 |
| Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a … R Lazarus, S Baos, H Cappel-Porter, A Carson-Stevens, M Clout, ... The Lancet 398 (10318), 2277-2287, 2021 | 133 | 2021 |
| High pro-inflammatory cytokine secretion and loss of high avidity cross-reactive cytotoxic T-cells during the course of secondary dengue virus infection T Dong, E Moran, N Vinh Chau, C Simmons, K Luhn, Y Peng, B Wills, ... PloS one 2 (12), e1192, 2007 | 133 | 2007 |
| Clinical features of 95 sequential hospitalised patients with novel coronavirus 2019 disease (COVID-19), the first UK cohort J Tomlins, F Hamilton, S Gunning, C Sheehy, E Moran, A MacGowan Journal of Infection 81 (2), e59-e61, 2020 | 95 | 2020 |
| Methylprednisolone acetate does not cause inflammatory changes in the epidural space. RS Cicala, R Turner, E Moran, R Henley, R Wong, J Evans Anesthesiology 72 (3), 556-558, 1990 | 84 | 1990 |
| Gram-negative bacteraemia; a multi-centre prospective evaluation of empiric antibiotic therapy and outcome in English acute hospitals JM Fitzpatrick, JS Biswas, JD Edgeworth, J Islam, N Jenkins, R Judge, ... Clinical Microbiology and Infection 22 (3), 244-251, 2016 | 78 | 2016 |
| Treatment of chronic or relapsing COVID-19 in immunodeficiency LAK Brown, E Moran, A Goodman, H Baxendale, W Bermingham, ... Journal of Allergy and Clinical Immunology 149 (2), 557-561. e1, 2022 | 63 | 2022 |
| Aerosol generating procedures: are they of relevance for transmission of SARS-CoV-2? F Hamilton, D Arnold, BR Bzdek, J Dodd, C White, J Murray, J Keller, ... The Lancet Respiratory Medicine 9 (7), 687-689, 2021 | 57 | 2021 |
| Aerosol emission from the respiratory tract: an analysis of aerosol generation from oxygen delivery systems FW Hamilton, FKA Gregson, DT Arnold, S Sheikh, K Ward, J Brown, ... Thorax 77 (3), 276-282, 2022 | 54 | 2022 |
| Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine (VLA2001) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the UK (COV-COMPARE … R Lazarus, B Querton, IC Ramljak, S Dewasthaly, JC Jaramillo, ... The Lancet Infectious Diseases 22 (12), 1716-1727, 2022 | 35 | 2022 |
| Preservation of a critical epitope core region is associated with the high degree of flaviviral cross‐reactivity exhibited by a dengue‐specific CD4+ T cell clone E Moran, C Simmons, N Vinh Chau, K Luhn, B Wills, NP Dung, LTT Thao, ... European journal of immunology 38 (4), 1050-1057, 2008 | 35 | 2008 |
| Therapeutic potential of IL6R blockade for the treatment of sepsis and sepsis-related death: A Mendelian randomisation study FW Hamilton, M Thomas, D Arnold, T Palmer, E Moran, AJ Mentzer, ... PLoS Medicine 20 (1), e1004174, 2023 | 34 | 2023 |
| Cerebral venous sinus thrombosis associated with COVID-19 A Thompson, C Morgan, P Smith, C Jones, H Ball, EJ Coulthard, E Moran, ... Practical neurology 21 (1), 75-76, 2021 | 34 | 2021 |
